Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
114.00    2.50 (2.24%)
Bid:
112.00
Ask:
116.00
Spread: 4.00 (3.571%)
Market Cap: £68.59m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Contract Update

23 Oct 2006 07:01

Intercede Group PLC23 October 2006 23 October 2006 INTERCEDE GROUP plc ('Intercede' or 'the Company') Contract Update Intercede is pleased to announce that an additional order for 200,000 MyIDlicenses has been received from Gemalto, bringing the total number of licensesordered to date to 500,000 in support of a single European public sectorcustomer. The robust and highly scalable nature of Intercede's MyID cardtechnology will enable this major customer to deliver card management servicesto over 1 million employees and contractors on a 24/7 basis. This project is oneof the largest employee focused smart card deployments in the world anddemonstrates the suitability of MyID for very large scale, complex environments. A number of key MyID features have been utilized to provide a fully scalable andintegrated solution, maximizing the use of existing infrastructure whileminimizing the risks and deployment time, including: • Integration with an in-house identity management system (IDMS) - to provide a single point of user interaction for all card and identity management • Customization of ID card issuance and management workflows to match required business processes - minimizing operator training requirements • Data retrieval from an existing central user data store - to avoid re-keying of information • Connection to a centralised Entrust Public Key Infrastructure (PKI) certificate authority for certificate production • Distributed deployment to more than 1,500 remote desktop enrolment and issuance stations for integrated card printing and chip encoding Richard Parris, Chairman and Chief Executive of Intercede, commented: "Following our recent success in the US Federal Government market, this latestorder demonstrates that MyID is able to provide both Government and CorporateEnterprises worldwide with the confidence and scalability that they require todeploy millions of smart card based identities. We are delighted to havereceived an additional license order from this prestigious Europeanorganization." About IntercedeIntercede Group plc is a leading developer and supplier of smart card andidentity management software listed on the London Stock Exchange (IGP LN)(IGP.L). The Group's MyID software manages the secure registration, issuance andlifecycle of digital identities for a wide range of uses. This requires theintegration of multiple technologies and products from many different vendors,including smart cards, USB authenticators, biometrics, digital certificates andOpen Platform applets. Intercede works with a number of market leading OEM, re-seller and technologypartners that supply MyID technology including: Athena Smartcard Solutions,Gemalto, RSA Security, SafeNet, Thales, VeriSign and a variety of systemsintegrators and other security product and service providers. Intercede and MyID are registered trademarks or trademarks in the UK, US and/orother countries. ENQUIRIES Intercede Group plc Tel. +44 (0)1455 558111Richard Parris, Chairman & Chief ExecutiveAndrew Walker, Finance Director Pelham Public Relations Tel. +44 (0)20 7743 6679Archie BerensKate Catchpole This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity
10th Aug 20227:00 amRNSNotice of AGM
30th Jun 20227:00 amRNSBoard Changes
8th Jun 20227:00 amRNSFinal Results
25th May 202210:15 amRNSInvestor Presentation
12th Apr 20227:00 amRNSAppointment of CFO
6th Apr 20227:00 amRNSDirector/PDMR Shareholding
5th Apr 20227:00 amRNSTrading Update & Contract Win
30th Mar 202210:01 amRNSReceipt of $3.4m Order
2nd Feb 20227:00 amRNSContract Win
8th Dec 20213:55 pmRNSDirector/PDMR Shareholding and Issue of Equity
23rd Nov 20217:00 amRNSHalf-year Report
19th Nov 20217:00 amRNSHolding(s) in Company-Amendment
17th Nov 20217:00 amRNSInvestor Presentation
16th Nov 20217:00 amRNSHolding(s) in Company
15th Nov 20213:45 pmRNSTotal Voting Rights
11th Nov 20214:12 pmRNSHolding(s) in Company
11th Oct 20217:00 amRNSTrading Update
15th Sep 20212:09 pmRNSResult of AGM
15th Sep 20217:00 amRNSMultiple Customers choose to Upgrade MyID

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.